Trials / Completed
CompletedNCT05535231
A Study to Evaluate the Effect of Turmeric in Healthy Participants
A Randomized, Double-Blinded, Comparator-Controlled, Crossover Study to Evaluate the Pharmacokinetics of Gaia Full-Spectrum Turmeric Phytocapsules
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Gaia Herbs Inc. · Industry
- Sex
- All
- Age
- 18 Years – 49 Years
- Healthy volunteers
- Accepted
Summary
Turmeric is recognized as a bioactive compound with potential benefits for human health. This study compares the pharmacokinetic profile of the Turmeric test product to a comparator.
Detailed description
This randomized, double-blinded, comparator-controlled, crossover study will compare the pharmacokinetic profile of the Turmeric test product to a comparator.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Turmeric test product | 2 capsules of 490 mg Turmeric are taken with water once |
| DIETARY_SUPPLEMENT | Turmeric comparator | 2 capsules of 200 mg Turmeric are taken with water once |
Timeline
- Start date
- 2022-09-24
- Primary completion
- 2022-10-03
- Completion
- 2022-10-03
- First posted
- 2022-09-10
- Last updated
- 2023-02-24
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT05535231. Inclusion in this directory is not an endorsement.